The ultimate goal of cancer studies is to fight and eliminate the dreading condition. This is what Oncotarget, an online medical research publication firm insists in their journals. An article titled “Nature Review Cancer from Oncotarget published on SCImago” addresses the importance of conducting diagnosis research on the oncology subject. To diagnose lesions that are precancerous, the article suggests the importance of understanding the main trigger of the cancer condition. This publication edited by Oncotarget shows how effective the journal is in promoting scientific research necessary to kick cancer out of the world.Another article from Oncotarget by Business Wire highlights the recent announcement by IntraGen about a publication deal they procured with Oncotarget. IntraGen, an oncology research company, announced that the results obtained from the study they did on tumor samples obtained from patients titled New EPOC were published by Oncotarget. Overall, this is a plus from Oncotarget as the move is seen to boost their publication portfolio. This step is also very vital in their research program campaign against cancer. The new EPOC results provide clinicians extra insights needed to develop cancer treatment solutions. With such results, Oncotarget is proud of making important strides each week in the fight against cancer. They are open to ideas and research contributions around the work, provided that the work addresses cancer.
Oncotarget is a weekly medical journal founded in 2010. They edit oncology research work globally and they forward the work to Impact Journals for publication. The firm is responsible for editing quality research work that provides cancer solution. The editing team is headed by Mikhail Blagosklonny and the team is effective in delivering verifiable cancer research solutions. The Publication is supplied with informed medical experts who are effective in delivering quality research. Recently, Oncotarget began releasing two articles a week. This is to meet the increasing demand for cancer treatment options. The move is seen as a future approach in the cancer campaign.
Oncotarget through impact Journal is effective in delivering cancer research work. They are able to welcome and edit research work addressing different medical fields such as Pathology, Microbiology, Immunology, and Aging conditions.